Elevance Health ROE 2012-2025 | ELV
Current and historical return on equity (ROE) values for Elevance Health (ELV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Elevance Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-12-31 | $5.66B | $43.65B | 12.97% |
| 2025-09-30 | $5.53B | $43.00B | 12.87% |
| 2025-06-30 | $5.36B | $42.94B | 12.48% |
| 2025-03-31 | $5.92B | $42.56B | 13.90% |
| 2024-12-31 | $5.98B | $42.08B | 14.21% |
| 2024-09-30 | $6.42B | $41.57B | 15.44% |
| 2024-06-30 | $6.69B | $40.24B | 16.63% |
| 2024-03-31 | $6.24B | $39.24B | 15.91% |
| 2023-12-31 | $5.99B | $38.43B | 15.58% |
| 2023-09-30 | $6.00B | $37.66B | 15.92% |
| 2023-06-30 | $6.31B | $37.04B | 17.04% |
| 2023-03-31 | $6.09B | $36.43B | 16.73% |
| 2022-12-31 | $5.89B | $36.07B | 16.34% |
| 2022-09-30 | $6.22B | $36.02B | 17.27% |
| 2022-06-30 | $6.13B | $35.96B | 17.04% |
| 2022-03-31 | $6.28B | $35.75B | 17.57% |
| 2021-12-31 | $6.16B | $35.23B | 17.48% |
| 2021-09-30 | $5.52B | $34.49B | 16.00% |
| 2021-06-30 | $4.23B | $34.02B | 12.44% |
| 2021-03-31 | $4.71B | $33.87B | 13.92% |
| 2020-12-31 | $4.57B | $33.32B | 13.72% |
| 2020-09-30 | $4.96B | $32.95B | 15.04% |
| 2020-06-30 | $5.92B | $32.30B | 18.31% |
| 2020-03-31 | $4.78B | $31.39B | 15.23% |
| 2019-12-31 | $4.81B | $30.96B | 15.53% |
| 2019-09-30 | $4.30B | $30.17B | 14.24% |
| 2019-06-30 | $4.07B | $29.61B | 13.76% |
| 2019-03-31 | $3.99B | $29.09B | 13.71% |
| 2018-12-31 | $3.75B | $28.34B | 13.23% |
| 2018-09-30 | $4.56B | $27.83B | 16.37% |
| 2018-06-30 | $4.34B | $27.05B | 16.06% |
| 2018-03-31 | $4.15B | $26.47B | 15.66% |
| 2017-12-31 | $3.84B | $26.24B | 14.64% |
| 2017-09-30 | $2.98B | $25.89B | 11.51% |
| 2017-06-30 | $2.85B | $25.59B | 11.14% |
| 2017-03-31 | $2.78B | $25.04B | 11.09% |
| 2016-12-31 | $2.47B | $24.41B | 10.12% |
| 2016-09-30 | $2.28B | $23.89B | 9.56% |
| 2016-06-30 | $2.32B | $23.52B | 9.87% |
| 2016-03-31 | $2.40B | $23.22B | 10.33% |
| 2015-12-31 | $2.56B | $23.42B | 10.93% |
| 2015-09-30 | $2.89B | $23.72B | 12.17% |
| 2015-06-30 | $2.86B | $23.99B | 11.93% |
| 2015-03-31 | $2.73B | $24.31B | 11.24% |
| 2014-12-31 | $2.57B | $24.32B | 10.57% |
| 2014-09-30 | $2.21B | $24.45B | 9.04% |
| 2014-06-30 | $2.24B | $24.57B | 9.10% |
| 2014-03-31 | $2.31B | $24.61B | 9.37% |
| 2013-12-31 | $2.49B | $24.61B | 10.12% |
| 2013-09-30 | $2.81B | $24.37B | 11.51% |
| 2013-06-30 | $2.84B | $24.12B | 11.78% |
| 2013-03-31 | $2.68B | $23.90B | 11.23% |
| 2012-12-31 | $2.66B | $23.70B | 11.21% |
| 2012-09-30 | $2.53B | $23.57B | 10.72% |
| 2012-06-30 | $2.52B | $23.55B | 10.70% |
| 2012-03-31 | $2.58B | $23.68B | 10.88% |
| 2011-12-31 | $2.65B | $23.79B | 11.13% |
| 2011-09-30 | $2.86B | $23.92B | 11.96% |
| 2011-06-30 | $2.92B | $24.08B | 12.11% |
| 2011-03-31 | $2.94B | $23.99B | 12.24% |
| 2010-12-31 | $2.89B | $24.12B | 11.97% |
| 2010-09-30 | $5.08B | $24.38B | 20.83% |
| 2010-06-30 | $5.07B | $24.01B | 21.12% |
| 2010-03-31 | $5.04B | $23.63B | 21.35% |
| 2009-12-31 | $4.75B | $22.87B | 20.75% |
| 2009-09-30 | $2.34B | $22.02B | 10.61% |
| 2009-06-30 | $2.43B | $21.72B | 11.17% |
| 2009-03-31 | $2.48B | $21.47B | 11.57% |
| 2008-12-31 | $2.49B | $21.47B | 11.60% |
| 2008-09-30 | $3.02B | $21.86B | 13.81% |
| 2008-06-30 | $3.07B | $22.36B | 13.71% |
| 2008-03-31 | $3.15B | $23.29B | 13.53% |
| 2007-12-31 | $3.35B | $24.20B | 13.82% |
| 2007-09-30 | $3.29B | $24.60B | 13.36% |
| 2007-06-30 | $3.23B | $24.71B | 13.07% |
| 2007-03-31 | $3.15B | $24.27B | 12.96% |
| 2006-12-31 | $3.10B | $24.02B | 12.89% |
| 2006-09-30 | $2.95B | $24.12B | 12.21% |
| 2006-06-30 | $2.78B | $23.40B | 11.87% |
| 2006-03-31 | $2.58B | $22.72B | 11.37% |
| 2005-12-31 | $2.46B | $21.70B | 11.36% |
| 2005-09-30 | $2.00B | $20.31B | 9.83% |
| 2005-06-30 | $1.60B | $16.70B | 9.57% |
| 2005-03-31 | $1.28B | $13.21B | 9.67% |
| 2004-12-31 | $0.96B | $9.80B | 9.81% |
| 2004-09-30 | $0.99B | $6.43B | 15.32% |
| 2004-06-30 | $0.94B | $6.19B | 15.18% |
| 2004-03-31 | $0.88B | $5.99B | 14.68% |
| 2003-12-31 | $0.78B | $5.77B | 13.44% |
| 2003-09-30 | $0.74B | $5.61B | 13.16% |
| 2003-06-30 | $0.71B | $5.47B | 13.01% |
| 2003-03-31 | $0.64B | $4.60B | 13.94% |
| 2002-12-31 | $0.55B | $3.76B | 14.60% |
| 2002-09-30 | $0.47B | $2.94B | 15.84% |
| 2002-06-30 | $0.41B | $2.15B | 18.90% |
| 2002-03-31 | $0.37B | $1.59B | 23.39% |
| 2001-12-31 | $0.34B | $1.06B | 32.40% |
| 2001-09-30 | $0.32B | $0.54B | 58.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $76.540B | $199.125B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.86 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.887B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |